Nigeria has officially received its first-ever shipment of malaria vaccines, a historic moment in the country’s long-standing battle against one of its deadliest diseases. The delivery, facilitated by Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization (WHO), marks a turning point in the fight to reduce malaria-related deaths, which have disproportionately affected Nigeria for decades.
The shipment arrived in Abuja and was formally handed over to the Nigerian government at a ceremony attended by top health officials, international partners, and representatives from Gavi and UNICEF. This milestone brings renewed hope in the battle against malaria, which claims nearly 200,000 lives annually in Nigeria alone, most of them children under the age of five.
Nigeria is considered the epicenter of malaria, shouldering the world’s highest burden of the disease. According to the latest data from the 2023 World Malaria Report, Nigeria accounts for 27% of global malaria cases and 31% of global malaria-related deaths. Despite years of interventions—including the distribution of insecticide-treated nets and the implementation of Seasonal Malaria Chemoprevention (SMC) programs—the disease remains pervasive across the country.
READ: 23 African countries now covered as Google expands flood alerts to 80 countries
The arrival of the vaccines is seen as a critical addition to the tools already in use. “This vaccine will play a monumental role in our efforts to reduce malaria deaths,” said Professor Muhammad Ali Pate, Nigeria’s Coordinating Minister of Health and Social Welfare. “We’ve made strides with other interventions, but with this vaccine, we’re getting closer to seeing a malaria-free Nigeria.”
The Rollout Plan
The malaria vaccine, which requires four doses to be fully effective, will be incorporated into Nigeria’s Routine Immunization program. The first phase of the rollout is scheduled to begin in November 2024, targeting high-burden areas such as Kebbi and Bayelsa States, where malaria prevalence is among the highest in the country. These regions will receive over 800,000 doses in the first round, with plans to expand distribution to other states in the months ahead.
Health authorities are prioritizing children under one year old, as they are the most vulnerable to the disease. The vaccine, which has been shown to significantly reduce the incidence of severe malaria, is expected to be a game-changer for communities where other preventive measures have fallen short.
The successful delivery of the vaccines to Nigeria is the result of extensive global collaboration. UNICEF, which managed the procurement and shipment of the vaccines, worked closely with Gavi and WHO to ensure the vaccines reached Nigeria on schedule. Gavi is also providing funding to cover the costs of distribution and administration, while the Nigerian government has pledged to support long-term deployment of the vaccines.
Cristian Munduate, UNICEF’s Representative in Nigeria, hailed the vaccine’s arrival as a transformative moment: “This vaccine brings hope to millions of families, especially in regions that have been devastated by malaria for years. We believe this is the beginning of a brighter, healthier future for children across Nigeria.”
Gavi’s Director of High Impact Countries, Tokunbo Oshin, emphasized the importance of continued international cooperation: “Malaria remains one of the deadliest diseases in Africa, and we can’t fight it alone. This vaccine rollout represents the power of global partnerships in saving lives.”
DON’T MISS: Google supports access to emergency maternal care in Nigeria
Jide
Read More